Latest News about AGIO
Recent news which mentions AGIO
7 Biotech Stocks That Could Be the Next Big Thing
March 15, 2023
From InvestorPlace
Agios Pharmaceuticals's Return On Capital Employed Insights
February 24, 2023
Tickers
AGIO
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
February 03, 2023
From Benzinga
3 Under-the-Radar Biotech Stocks to Buy in 2022
December 24, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
November 17, 2022
From Benzinga
Agios Pharmaceuticals's Return On Capital Employed Overview
November 17, 2022
Tickers
AGIO
From Benzinga
Europe Approves Agios Pharma's Mitapivat For Adult Pyruvate Kinase Deficiency Patients
November 11, 2022
Tickers
AGIO
From Benzinga
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday
September 02, 2022
From Benzinga
Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session
September 01, 2022
From Benzinga
Nutanix, Five Below And Some Other Big Stocks Moving Higher On Thursday
September 01, 2022
From Benzinga
Looking Into Agios Pharmaceuticals Return On Capital Employed
August 15, 2022
Tickers
AGIO
From Benzinga
From Benzinga
From Benzinga
From Benzinga
U.S. Stock Futures Higher; All Eyes On Inflation Data
July 13, 2022
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Friday
May 27, 2022
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
What 4 Analyst Ratings Have To Say About Agios Pharmaceuticals
February 22, 2022
Tickers
AGIO
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.